Zygolide® is the first-to-market, FDA-approved generic peppermint flavored pergolide tablet for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses.
  • Each tablet contains 1 mg of pergolide and is bioequivalent to the pioneer product when administered orally to horses.
  • FDA approval of generics requires rigorous testing to confirm bioequivalence, which ensures the same safety, efficacy, and therapeutic effect as the pioneer product. You can expect Zygolide® to perform to the same clinical standard, even in challenging cases.
  • Zygolide® is formulated to appeal to horses, helping to ensure consistent daily dosing for effective management of PPID. It is a 360-degree half-scored tablet to help with accurate dosing.
Want to learn more?
Download our support materials below and contact our Veterinary Technical Support team at support@dechra.com or by calling (866) 933-2472.
Start Here
to place an order!